Gelteq Limited Ordinary Shares(GELS)Earnings, Financials & Key Ratios
GELS•NASDAQ
$0.47
$5M mkt cap·Price updated May 7, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryContract development and manufacturing services
AboutGelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.Show more
- Revenue$0-100.0%
- EBITDA-$2M+7.5%
- Net Income-$4M-1.1%
- EPS (Diluted)0.00+100.0%
- ROE-21%-18.3%
- ROIC-11.14%-2.8%
- Debt/Equity0.25+90.7%
- Interest Coverage-5.03+34.5%
GELS Key Insights
Gelteq Limited Ordinary Shares (GELS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Share count reduced 100.0% through buybacks
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Weak momentum: RS Rating 9 (bottom 9%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
GELS Price & Volume
Gelteq Limited Ordinary Shares (GELS) stock price & volume — 10-year historical chart
Loading chart...
GELS Growth Metrics
Gelteq Limited Ordinary Shares (GELS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-
Return on Capital
10 Years-12.22%
5 Years-12.22%
3 Years-14.52%
Last Year-15.5%
GELS Peer Comparison
Gelteq Limited Ordinary Shares (GELS) competitors in Contract development and manufacturing services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ATXI | 1.75M | 0.55 | -0.61 | -266.67% | -160.63% | |||
 DARE | 25.32M | 2.91 | -6.06 | -99.65% | -6.11% | |||
 NUVB | 1.67B | 4.82 | -8.03 | 6.99% | -102.06% | -44.1% | 0.03 | |
 PRAX | 9.63B | 333.28 | -24.72 | -100% | -43.02% | 0.00 | ||
 AQST | 516.25M | 4.23 | -5.57 | -22.61% | -188.09% | |||
 ORMP | 159.7M | 3.91 | -8.32 | -100% | -12.08% | -15.73% | 0.00 | |
 PCRX | 929.88M | 23.64 | 147.75 | 3.63% | 1.27% | 1.31% | 0.66 | |
 PAHC | 1.75B | 43.16 | 36.27 | 27.37% | 6.29% | 30.81% | 2.67 |
Compare GELS vs Peers
Gelteq Limited Ordinary Shares (GELS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GELS Income Statement
Gelteq Limited Ordinary Shares (GELS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 |
|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 147.54K | 79.84K | 0 |
| Revenue Growth % | - | - | - | -45.88% | -100% |
| Cost of Goods Sold | 0 | 0 | 94.87K | 48.92K | 0 |
| COGS % of Revenue | - | - | 64.31% | 61.28% | - |
| Gross Profit | 0▲ 0% | 0▲ 0% | 52.66K▲ 0% | 30.92K▼ 41.3% | 0▼ 100.0% |
| Gross Margin % | - | - | 35.69% | 38.72% | - |
| Gross Profit Growth % | - | - | - | -41.29% | -100% |
| Operating Expenses | 529.62K | 647.62K | 3.25M | 3.13M | 2.95M |
| OpEx % of Revenue | - | - | 2200.09% | 3924.04% | - |
| Selling, General & Admin | 230.52K | 463.73K | 1.55M | 1.7M | 1.27M |
| SG&A % of Revenue | - | - | 1048.19% | 2126.49% | - |
| Research & Development | 342.36K | 277.06K | 529.02K | 665.03K | 276.06K |
| R&D % of Revenue | - | - | 358.57% | 832.93% | - |
| Other Operating Expenses | -43.26K | -93.16K | 1.17M | 770.18K | 1.4M |
| Operating Income | 0▲ 0% | -647.62K▲ 0% | -3.19M▼ 393.1% | -3.1M▲ 2.9% | -2.95M▲ 5.0% |
| Operating Margin % | - | - | -2164.39% | -3885.31% | - |
| Operating Income Growth % | - | - | -393.07% | 2.85% | 5.03% |
| EBITDA | -527.23K | -589.68K | -1.98M | -1.88M | -1.73M |
| EBITDA Margin % | - | - | -1340.69% | -2349.19% | - |
| EBITDA Growth % | - | -11.84% | -235.44% | 5.17% | 7.55% |
| D&A (Non-Cash Add-back) | 2.39K | 57.95K | 1.22M | 1.23M | 1.21M |
| EBIT | -529.62K | -647.62K | -3.19M | -3.1M | -2.96M |
| Net Interest Income | 0 | -1.3K | -175.63K | -404.07K | -600.22K |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 1.3K | 174.5K | 403.52K | 585.12K |
| Other Income/Expense | -529.62K | -1.3K | -175.63K | -404.07K | -600.22K |
| Pretax Income | -529.62K▲ 0% | -648.92K▼ 22.5% | -3.37M▼ 419.2% | -3.51M▼ 4.1% | -3.55M▼ 1.1% |
| Pretax Margin % | - | - | -2283.44% | -4391.39% | - |
| Income Tax | -154.03K | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 29.08% | 0% | 0% | 0% | 0% |
| Net Income | -375.59K▲ 0% | -648.92K▼ 72.8% | -3.37M▼ 419.2% | -3.51M▼ 4.1% | -3.55M▼ 1.1% |
| Net Margin % | - | - | -2283.44% | -4391.39% | - |
| Net Income Growth % | - | -72.78% | -419.15% | -4.08% | -1.14% |
| Net Income (Continuing) | -375.59K | -648.92K | -3.37M | -3.51M | -3.55M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.16▲ 0% | -0.07▲ 57.0% | -0.36▼ 423.3% | -0.37▼ 2.8% | 0.00▲ 100.0% |
| EPS Growth % | - | 57% | -423.26% | -2.78% | 100% |
| EPS (Basic) | -0.16 | -0.07 | -0.36 | -0.37 | 0.00 |
| Diluted Shares Outstanding | 2.35M | 9.44M | 9.44M | 9.44M | 0 |
| Basic Shares Outstanding | 2.35M | 9.44M | 9.44M | 9.44M | 0 |
| Dividend Payout Ratio | - | - | - | - | - |
GELS Balance Sheet
Gelteq Limited Ordinary Shares (GELS) balance sheet — assets, liabilities & shareholders' equity
| Line item | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 |
|---|---|---|---|---|---|
| Total Current Assets | 574.5K | 374.91K | 720.07K | 990.97K | 303.23K |
| Cash & Short-Term Investments | 319.52K | 181.66K | 162.49K | 399.22K | 24.52K |
| Cash Only | 319.52K | 181.66K | 162.49K | 399.22K | 24.52K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 254.98K | 193.25K | 250.67K | 345.29K | 183K |
| Days Sales Outstanding | - | - | 620.14 | 1.58K | - |
| Inventory | 0 | 0 | 95.2K | 95.2K | 0 |
| Days Inventory Outstanding | - | - | 366.26 | 710.24 | - |
| Other Current Assets | 0 | 0 | 98.75K | 3.79K | 16.07K |
| Total Non-Current Assets | 44.62K | 23.84M | 22.69M | 21.5M | 20.45M |
| Property, Plant & Equipment | 0 | 0 | 40K | 10K | 16.64K |
| Fixed Asset Turnover | - | - | 3.69x | 7.98x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 44.62K | 23.84M | 22.65M | 21.49M | 20.44M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 619.12K▲ 0% | 24.22M▲ 3811.9% | 23.41M▼ 3.3% | 22.49M▼ 3.9% | 20.76M▼ 7.7% |
| Asset Turnover | - | - | 0.01x | 0.00x | - |
| Asset Growth % | - | 3811.86% | -3.34% | -3.91% | -7.72% |
| Total Current Liabilities | 229.94K | 235.9K | 1.08M | 1.36M | 3.87M |
| Accounts Payable | 170.34K | 85.13K | 216.72K | 291.27K | 387.03K |
| Days Payables Outstanding | - | - | 833.79 | 2.17K | - |
| Short-Term Debt | 4.59K | 4.8K | 5.09K | 5.09K | 2.08M |
| Deferred Revenue (Current) | 0 | 0 | 119.77K | 85.36K | 125.36K |
| Other Current Liabilities | 0 | 6.94K | 39.52K | 77.78K | 98.37K |
| Current Ratio | 2.50x | 1.59x | 0.67x | 0.73x | 0.08x |
| Quick Ratio | 2.50x | 1.59x | 0.58x | 0.66x | 0.08x |
| Cash Conversion Cycle | - | - | 152.61 | 115.74 | - |
| Total Non-Current Liabilities | 166.11K | 167.33K | 1.47M | 2.47M | 1.78M |
| Long-Term Debt | 166.11K | 167.33K | 1.46M | 2.47M | 1.76M |
| Capital Lease Obligations | 0 | 0 | 11.9K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 20.02K |
| Total Liabilities | 396.04K | 403.23K | 2.55M | 3.84M | 5.65M |
| Total Debt | 170.7K | 172.12K | 1.51M | 2.49M | 3.84M |
| Net Debt | -148.82K | -9.54K | 1.35M | 2.09M | 3.82M |
| Debt / Equity | 0.77x | 0.01x | 0.07x | 0.13x | 0.25x |
| Debt / EBITDA | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - |
| Interest Coverage | - | -499.32x | -18.30x | -7.69x | -5.03x |
| Total Equity | 223.07K▲ 0% | 23.82M▲ 10576.2% | 20.86M▼ 12.4% | 18.66M▼ 10.5% | 15.11M▼ 19.0% |
| Equity Growth % | - | 10576.22% | -12.43% | -10.53% | -19.01% |
| Book Value per Share | 0.10 | 2.52 | 2.21 | 1.98 | - |
| Total Shareholders' Equity | 223.07K | 23.82M | 20.86M | 18.66M | 15.11M |
| Common Stock | 300.23K | 24.93M | 25.3M | 26.61M | 26.61M |
| Retained Earnings | -460.43K | -1.11M | -4.48M | -7.95M | -11.5M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 34.72K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
GELS Cash Flow Statement
Gelteq Limited Ordinary Shares (GELS) cash flow — operating, investing & free cash flow history
| Line item | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 |
|---|---|---|---|---|---|
| Cash from Operations | 0 | 0 | 0 | -1.77M | -1.07M |
| Operating CF Margin % | - | - | - | -2217.4% | - |
| Operating CF Growth % | - | - | - | - | 39.54% |
| Net Income | 0 | 0 | 0 | -3.51M | -3.55M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 0 | 0 | 1.74M | 2.48M |
| Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -10K | 138.89K | 0 | -75.93K | -148.17K |
| Capital Expenditures | 0 | 0 | 0 | -34.5K | -3.15K |
| CapEx % of Revenue | - | - | - | 43.21% | - |
| Acquisitions | 0 | 138.89K | 0 | 0 | 0 |
| Investments | - | - | - | - | - |
| Other Investing | -10K | 0 | 0 | -41.43K | -145.02K |
| Cash from Financing | 681.55K | 200 | 1.49M | 2.03M | 843.94K |
| Debt Issued (Net) | 57.88K | 200 | 1.49M | 721.23K | 843.94K |
| Equity Issued (Net) | 300.02K | 0 | 0 | 1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 323.64K | 0 | 0 | -121.84K | 0 |
| Net Change in Cash | 317.44K▲ 0% | -137.85K▼ 143.4% | -19.18K▲ 86.1% | 236.74K▲ 1334.4% | -374.7K▼ 258.3% |
| Free Cash Flow | -354.11K▲ 0% | -276.95K▲ 21.8% | -1.51M▼ 444.5% | -1.85M▼ 22.4% | -1.22M▲ 34.0% |
| FCF Margin % | - | - | -1022.08% | -2312.5% | - |
| FCF Growth % | - | 21.79% | -444.48% | -22.44% | 34% |
| FCF per Share | -0.15 | -0.03 | -0.16 | -0.20 | - |
| FCF Conversion (FCF/Net Income) | - | - | - | 0.50x | 0.30x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 |
GELS Key Ratios
Gelteq Limited Ordinary Shares (GELS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | -168.37% | -5.4% | -15.08% | -17.75% | -21% |
| Return on Invested Capital (ROIC) | - | -4.07% | -10.41% | -10.83% | -11.14% |
| Gross Margin | - | - | 35.69% | 38.72% | - |
| Net Margin | - | - | -2283.44% | -4391.39% | - |
| Debt / Equity | 0.77x | 0.01x | 0.07x | 0.13x | 0.25x |
| Interest Coverage | - | -499.32x | -18.30x | -7.69x | -5.03x |
| FCF Conversion | - | - | - | 0.50x | 0.30x |
| Revenue Growth | - | - | - | -45.88% | -100% |
GELS Frequently Asked Questions
Gelteq Limited Ordinary Shares (GELS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Gelteq Limited Ordinary Shares (GELS) reported $0.1M in revenue for fiscal year 2024.
Gelteq Limited Ordinary Shares (GELS) saw revenue decline by 100.0% over the past year.
Gelteq Limited Ordinary Shares (GELS) reported a net loss of $4.0M for fiscal year 2024.
Dividend & Returns
Gelteq Limited Ordinary Shares (GELS) has a return on equity (ROE) of -21.0%. Negative ROE indicates the company is unprofitable.
Gelteq Limited Ordinary Shares (GELS) had negative free cash flow of $1.8M in fiscal year 2024, likely due to heavy capital investments.
Explore More GELS
Gelteq Limited Ordinary Shares (GELS) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates